Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) EBITDA (2016 - 2025)

Historic EBITDA for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $40.1 million.

  • Bio-Techne's EBITDA rose 32950.57% to $40.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $104.4 million, marking a year-over-year decrease of 2331.14%. This contributed to the annual value of $91.8 million for FY2025, which is 4107.52% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's EBITDA is $40.1 million, which was up 32950.57% from $33.7 million recorded in Q3 2025.
  • Bio-Techne's 5-year EBITDA high stood at $84.9 million for Q4 2021, and its period low was $4.5 million during Q2 2025.
  • In the last 5 years, Bio-Techne's EBITDA had a median value of $41.6 million in 2022 and averaged $46.9 million.
  • The largest annual percentage gain for Bio-Techne's EBITDA in the last 5 years was 32950.57% (2025), contrasted with its biggest fall of 8804.12% (2025).
  • Over the past 5 years, Bio-Techne's EBITDA (Quarter) stood at $84.9 million in 2021, then fell by 21.46% to $66.7 million in 2022, then plummeted by 37.29% to $41.8 million in 2023, then tumbled by 77.7% to $9.3 million in 2024, then soared by 329.51% to $40.1 million in 2025.
  • Its EBITDA was $40.1 million in Q4 2025, compared to $33.7 million in Q3 2025 and $4.5 million in Q2 2025.